Literature DB >> 19417051

The evolution of evidence hierarchies: what can Bradford Hill's 'guidelines for causation' contribute?

Jeremy Howick1, Paul Glasziou, Jeffrey K Aronson.   

Abstract

Mesh：

Year:  2009        PMID： 19417051      PMCID： PMC2677430          DOI： 10.1258/jrsm.2009.090020

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  43 in total

1.  Applying Bradford Hill's criteria for causation to neuropsychiatry: challenges and opportunities.

Authors:  R van Reekum; D L Streiner; D K Conn
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2001       Impact factor: 2.198

Review 2.  Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials.

Authors:  Gordon C S Smith; Jill P Pell
Journal:  BMJ       Date:  2003-12-20

Review 3.  Observational versus experimental studies: what's the evidence for a hierarchy?

Authors:  John Concato
Journal:  NeuroRx       Date:  2004-07

4.  Unity from diversity: the evidential use of anecdotal reports of adverse drug reactions and interactions.

Authors:  Jeffrey K Aronson
Journal:  J Eval Clin Pract       Date:  2005-04       Impact factor: 2.431

5.  The multiple outcomes bias in antidepressants research.

Authors:  Marco Procopio
Journal:  Med Hypotheses       Date:  2005       Impact factor: 1.538

6.  When are randomised trials unnecessary? Picking signal from noise.

Authors:  Paul Glasziou; Iain Chalmers; Michael Rawlins; Peter McCulloch
Journal:  BMJ       Date:  2007-02-17

7.  Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.

Authors:  Gilda Piaggio; Diana R Elbourne; Douglas G Altman; Stuart J Pocock; Stephen J W Evans
Journal:  JAMA       Date:  2006-03-08       Impact factor: 56.272

8.  Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study.

Authors:  Lesley Wood; Matthias Egger; Lise Lotte Gluud; Kenneth F Schulz; Peter Jüni; Douglas G Altman; Christian Gluud; Richard M Martin; Anthony J G Wood; Jonathan A C Sterne
Journal:  BMJ       Date:  2008-03-03

9.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

10.  The missed lessons of Sir Austin Bradford Hill.

Authors:  Carl V Phillips; Karen J Goodman
Journal:  Epidemiol Perspect Innov       Date:  2004-10-04
View more
  39 in total

1.  Pharmacovigilance.

Authors:  I Ralph Edwards
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

2.  Evidence-based mechanistic reasoning.

Authors:  Jeremy Howick; Paul Glasziou; Jeffrey K Aronson
Journal:  J R Soc Med       Date:  2010-11       Impact factor: 5.344

3.  Time, space and form: Necessary for causation in health, disease and intervention?

Authors:  David W Evans; Nicholas Lucas; Roger Kerry
Journal:  Med Health Care Philos       Date:  2016-06

Review 4.  Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.

Authors:  Alberto J Espay; Joaquin A Vizcarra; Luca Marsili; Anthony E Lang; David K Simon; Aristide Merola; Keith A Josephs; Alfonso Fasano; Francesca Morgante; Rodolfo Savica; J Timothy Greenamyre; Franca Cambi; Tritia R Yamasaki; Caroline M Tanner; Ziv Gan-Or; Irene Litvan; Ignacio F Mata; Cyrus P Zabetian; Patrik Brundin; Hubert H Fernandez; David G Standaert; Marcelo A Kauffman; Michael A Schwarzschild; S Pablo Sardi; Todd Sherer; George Perry; James B Leverenz
Journal:  Neurology       Date:  2019-02-12       Impact factor: 9.910

5.  Causal assessment of pharmaceutical treatments: why standards of evidence should not be the same for benefits and harms?

Authors:  Barbara Osimani; Fiorenzo Mignini
Journal:  Drug Saf       Date:  2015-01       Impact factor: 5.606

Review 6.  An Abductive Inference Approach to Assess the Performance-Enhancing Effects of Drugs Included on the World Anti-Doping Agency Prohibited List.

Authors:  Andreas Breenfeldt Andersen; Glenn A Jacobson; Jacob Bejder; Dino Premilovac; Stephen M Richards; Jon J Rasmussen; Søren Jessen; Morten Hostrup
Journal:  Sports Med       Date:  2021-04-02       Impact factor: 11.136

7.  Markers of inflammation in schizophrenia: association vs. causation.

Authors:  Peter Manu; Christoph U Correll; Martien Wampers; Alex J Mitchell; Michel Probst; Davy Vancampfort; Marc De Hert
Journal:  World Psychiatry       Date:  2014-06       Impact factor: 49.548

8.  The nosological classification of whiplash-associated disorder: a narrative review.

Authors:  Joe H Ghorayeb
Journal:  J Can Chiropr Assoc       Date:  2021-04

9.  Causality Assessment in Pharmacovigilance: Still a Challenge.

Authors:  I Ralph Edwards
Journal:  Drug Saf       Date:  2017-05       Impact factor: 5.606

Review 10.  Therapeutic intervention in oropharyngeal dysphagia.

Authors:  Rosemary Martino; Timothy McCulloch
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-14       Impact factor: 46.802
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.